$253 Million is the total value of Altium Capital Management LP's 72 reported holdings in Q1 2024. The portfolio turnover from Q4 2023 to Q1 2024 was 81.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| VERA | Buy | VERA THERAPEUTICS INCcl a | $30,615,200 | +223.7% | 710,000 | +15.4% | 12.12% | +88.7% |
| XENE | Buy | XENON PHARMACEUTICALS INC | $14,981,400 | +12.0% | 348,000 | +19.8% | 5.93% | -34.7% |
| New | VIKING THERAPEUTICS INCput | $14,374,600 | – | 175,300 | +100.0% | 5.69% | – | |
| New | ADVISORSHARES TRcall | $11,261,250 | – | 1,125,000 | +100.0% | 4.46% | – | |
| AXSM | AXSOME THERAPEUTICS INC | $11,012,400 | +0.3% | 138,000 | 0.0% | 4.36% | -41.6% | |
| ADMA | Buy | ADMA BIOLOGICS INC | $10,164,000 | +105.4% | 1,540,000 | +40.6% | 4.02% | +19.7% |
| Sell | ALIMERA SCIENCES INC | $9,945,000 | -13.5% | 2,550,000 | -4.1% | 3.94% | -49.5% | |
| AVDL | New | AVADEL PHARMACEUTICALS PLCsponsored adr | $9,341,133 | – | 553,057 | +100.0% | 3.70% | – |
| XTNT | Sell | XTANT MED HLDGS INC | $8,948,011 | -1.4% | 7,647,873 | -4.7% | 3.54% | -42.5% |
| CPRX | Buy | CATALYST PHARMACEUTICALS INC | $7,970,000 | +23.1% | 500,000 | +29.9% | 3.15% | -28.2% |
| ITCI | Buy | INTRA-CELLULAR THERAPIES INC | $7,819,600 | +53.8% | 113,000 | +59.2% | 3.10% | -10.3% |
| New | BIOHAVEN LTD | $7,656,600 | – | 140,000 | +100.0% | 3.03% | – | |
| VKTX | New | VIKING THERAPEUTICS INC | $6,970,000 | – | 85,000 | +100.0% | 2.76% | – |
| OLMA | Buy | OLEMA PHARMACEUTICALS INC | $6,848,600 | +18.0% | 605,000 | +46.3% | 2.71% | -31.2% |
| SVRA | Buy | SAVARA INC | $6,648,300 | +6.1% | 1,335,000 | +0.2% | 2.63% | -38.1% |
| Buy | SOLENO THERAPEUTICS INC | $6,544,505 | +55.0% | 152,909 | +45.8% | 2.59% | -9.6% | |
| CLXPF | New | CYBIN INC | $5,769,767 | – | 13,953,488 | +100.0% | 2.28% | – |
| ORIC | Sell | ORIC PHARMACEUTICALS INC | $5,568,750 | -10.5% | 405,000 | -40.1% | 2.20% | -47.8% |
| LRMR | New | LARIMAR THERAPEUTICS INC | $5,275,050 | – | 695,000 | +100.0% | 2.09% | – |
| MIRM | New | MIRUM PHARMACEUTICALS INC | $5,224,960 | – | 208,000 | +100.0% | 2.07% | – |
| Buy | NEUROGENE INC | $5,090,000 | +292.1% | 100,000 | +49.3% | 2.01% | +128.6% | |
| New | PRAXIS PRECISION MEDICINES I | $4,765,662 | – | 78,100 | +100.0% | 1.89% | – | |
| New | ACHIEVE LIFE SCIENCES INC | $3,797,211 | – | 835,470 | +100.0% | 1.50% | – | |
| ASND | ASCENDIS PHARMA A/Ssponsored adr | $3,779,250 | +20.0% | 25,000 | 0.0% | 1.50% | -30.0% | |
| LBPH | New | LONGBOARD PHARMACEUTICALS IN | $3,672,000 | – | 170,000 | +100.0% | 1.45% | – |
| INSM | INSMED INC | $3,255,600 | -12.5% | 120,000 | 0.0% | 1.29% | -49.0% | |
| REAL | New | THE REALREAL INC | $3,128,000 | – | 800,000 | +100.0% | 1.24% | – |
| ALPN | Sell | ALPINE IMMUNE SCIENCES INC | $3,085,895 | +105.7% | 77,848 | -1.1% | 1.22% | +19.8% |
| New | BOUNDLESS BIO INC | $2,850,000 | – | 200,000 | +100.0% | 1.13% | – | |
| AQST | New | AQUESTIVE THERAPEUTICS INC | $2,832,900 | – | 665,000 | +100.0% | 1.12% | – |
| RYTM | Buy | RHYTHM PHARMACEUTICALS INC | $2,481,552 | +732.4% | 57,271 | +783.1% | 0.98% | +386.1% |
| MIST | New | MILESTONE PHARMACEUTICALS IN | $2,171,059 | – | 1,212,882 | +100.0% | 0.86% | – |
| Sell | ASTRIA THERAPEUTICS INC | $2,006,138 | -64.2% | 142,532 | -80.5% | 0.79% | -79.1% | |
| KMPH | New | ZEVRA THERAPEUTICS INC | $1,980,474 | – | 341,461 | +100.0% | 0.78% | – |
| New | RAPT THERAPEUTICS INCcall | $1,796,000 | – | 200,000 | +100.0% | 0.71% | – | |
| Sell | MARINUS PHARMACEUTICALS INC | $1,598,634 | -26.5% | 176,840 | -11.6% | 0.63% | -57.1% | |
| BIVI | New | BIOVIE INCcl a new | $1,592,465 | – | 3,012,608 | +100.0% | 0.63% | – |
| New | TOURMALINE BIO INC | $1,498,622 | – | 65,442 | +100.0% | 0.59% | – | |
| VERU | Buy | VERU INC | $1,478,423 | +2.7% | 2,111,731 | +5.6% | 0.58% | -40.2% |
| New | GERON CORPcall | $1,320,000 | – | 400,000 | +100.0% | 0.52% | – | |
| KPTI | KARYOPHARM THERAPEUTICS INC | $1,117,400 | +74.6% | 740,000 | 0.0% | 0.44% | +1.6% | |
| FATBW | FAT BRANDS INC*w exp 07/16/202 | $974,000 | +43.2% | 200,000 | 0.0% | 0.38% | -16.7% | |
| SPRB | New | SPRUCE BIOSCIENCES INC | $903,785 | – | 1,150,000 | +100.0% | 0.36% | – |
| ISR | New | PERSPECTIVE THERAPEUTICS INC | $637,432 | – | 535,657 | +100.0% | 0.25% | – |
| New | EVOKE PHARMA INC | $442,215 | – | 724,942 | +100.0% | 0.18% | – | |
| New | PERFECT MOMENT LTD | $330,105 | – | 92,208 | +100.0% | 0.13% | – | |
| New | ROCKET PHARMACEUTICALS INC*w exp 09/02/202 | $218,883 | – | 731,561 | +100.0% | 0.09% | – | |
| NEXGEL INC*w exp 12/01/202 | $162,000 | +46.9% | 225,000 | 0.0% | 0.06% | -14.7% | ||
| New | MOBILICOM LTDspon ads | $160,997 | – | 135,292 | +100.0% | 0.06% | – | |
| New | GRI BIO INC | $142,866 | – | 187,981 | +100.0% | 0.06% | – | |
| WEARABLE DEVICES LTD*w exp 09/14/202 | $109,470 | +10.8% | 1,411,600 | 0.0% | 0.04% | -35.8% | ||
| New | AZITRA INC | $101,343 | – | 493,153 | +100.0% | 0.04% | – | |
| MBTCR | NOCTURNE ACQUISITION CORPright 12/26/2025 | $82,000 | -0.5% | 500,000 | 0.0% | 0.03% | -42.9% | |
| New | QUOIN PHARMACEUTICALS LTDsponsored ads | $62,928 | – | 66,240 | +100.0% | 0.02% | – | |
| MOBIX LABS INC*w exp 99/99/999 | $31,500 | +199.1% | 150,000 | 0.0% | 0.01% | +71.4% | ||
| DIGITAL HEALTH ACQUISITION C*w exp 99/99/999 | $19,245 | +392.5% | 150,000 | 0.0% | 0.01% | +166.7% | ||
| ONFOLIO HOLDINGS INC*w exp 01/02/202 | $8,120 | -49.2% | 200,000 | 0.0% | 0.00% | -72.7% | ||
| NLSPW | NLS PHARMACEUTICS LTD*w exp 02/02/202 | $6,880 | -38.7% | 200,000 | 0.0% | 0.00% | -62.5% | |
| BITCOIN DEPOT INC*w exp 06/30/202 | $4,745 | -34.6% | 50,000 | 0.0% | 0.00% | -60.0% | ||
| CONDUIT PHARMACEUTICALS INC*w exp 09/22/202 | $6,000 | -13.4% | 100,000 | 0.0% | 0.00% | -60.0% | ||
| NEXALIN TECHNOLOGY INC*w exp 99/99/999 | $4,389 | +375.0% | 105,000 | 0.0% | 0.00% | +100.0% | ||
| CINGULATE INC*w exp 12/10/202 | $5,697 | -29.7% | 270,000 | 0.0% | 0.00% | -60.0% | ||
| WESTERN ACQSTN VENTURES CORP*w exp 99/99/999 | $4,275 | +34.0% | 100,000 | 0.0% | 0.00% | 0.0% | ||
| JEFFS BRANDS LTD*w exp 99/99/999 | $4,011 | +54.9% | 68,681 | 0.0% | 0.00% | 0.0% | ||
| CEA INDUSTRIES INC*w exp 02/11/202 | $3,250 | +8.8% | 250,000 | 0.0% | 0.00% | -50.0% | ||
| PROSOMNUS INC*w exp 04/20/202 | $3,000 | -29.6% | 150,000 | 0.0% | 0.00% | -66.7% | ||
| COLISEUM ACQUISITION CORP*w exp 08/22/202 | $1,870 | +65.0% | 28,333 | 0.0% | 0.00% | 0.0% | ||
| SURROZEN INC*w exp 08/01/203 | $3,404 | +135.9% | 82,233 | 0.0% | 0.00% | 0.0% | ||
| TC BIOPHARM HOLDINGS PLC*w exp 02/10/202 | $376 | -38.6% | 18,823 | 0.0% | 0.00% | – | ||
| RELATIVITY ACQUISITION CORP*w exp 12/15/202 | $0 | – | 100,000 | 0.0% | 0.00% | – | ||
| BRUUSH ORAL CARE INC*w exp 08/03/202 | $110 | +12.2% | 14,423 | 0.0% | 0.00% | – | ||
| SELINA HOSPITALITY PLC*w exp 10/27/202 | $710 | +66.7% | 101,439 | 0.0% | 0.00% | – | ||
| Exit | TG VENTURE ACQUISITION CORP*w exp 08/15/202 | $0 | – | -200,000 | -100.0% | -0.00% | – | |
| Exit | PEPPERLIME HEALTH ACQUSTN CO*w exp 10/01/202 | $0 | – | -367,500 | -100.0% | -0.01% | – | |
| Exit | NOVABAY PHARMACEUTICALS INC | $0 | – | -67,457 | -100.0% | -0.01% | – | |
| GRIL | Exit | SADOT GROUP INC | $0 | – | -168,235 | -100.0% | -0.05% | – |
| Exit | CYCLACEL PHARMACEUTICALS INC | $0 | – | -37,982 | -100.0% | -0.07% | – | |
| Exit | TONIX PHARMACEUTICALS HLDG C | $0 | – | -540,025 | -100.0% | -0.15% | – | |
| SAVA | Exit | CASSAVA SCIENCES INC | $0 | – | -13,000 | -100.0% | -0.20% | – |
| Exit | DOUBLEDOWN INTERACTIVE CO LTads | $0 | – | -60,876 | -100.0% | -0.30% | – | |
| Exit | BIOXCEL THERAPEUTICS INCput | $0 | – | -169,200 | -100.0% | -0.34% | – | |
| MSOS | Exit | ADVISORSHARES TRpure us cannabis | $0 | – | -80,000 | -100.0% | -0.38% | – |
| Exit | ACURX PHARMACEUTICALS INCput | $0 | – | -170,300 | -100.0% | -0.44% | – | |
| DMAC | Exit | DIAMEDICA THERAPEUTICS INC | $0 | – | -287,698 | -100.0% | -0.56% | – |
| Exit | CASSAVA SCIENCES INCput | $0 | – | -47,000 | -100.0% | -0.72% | – | |
| Exit | FORTRESS BIOTECH INC | $0 | – | -405,122 | -100.0% | -0.83% | – | |
| ARVN | Exit | ARVINAS INC | $0 | – | -31,210 | -100.0% | -0.87% | – |
| CYTK | Exit | CYTOKINETICS INC | $0 | – | -20,000 | -100.0% | -1.13% | – |
| Exit | AMYLYX PHARMACEUTICALS INC | $0 | – | -119,526 | -100.0% | -1.19% | – | |
| Exit | ENVVENO MEDICAL CORPORATION | $0 | – | -344,471 | -100.0% | -1.20% | – | |
| CRNX | Exit | CRINETICS PHARMACEUTICALS IN | $0 | – | -65,000 | -100.0% | -1.57% | – |
| Exit | SAGIMET BIOSCIENCES INC | $0 | – | -483,181 | -100.0% | -1.72% | – | |
| CBAY | Exit | CYMABAY THERAPEUTICS INC | $0 | – | -111,000 | -100.0% | -1.78% | – |
| IMVT | Exit | IMMUNOVANT INC | $0 | – | -80,000 | -100.0% | -2.29% | – |
| Exit | EA SERIES TRUSTalpha arch 1-3 | $0 | – | -92,700 | -100.0% | -6.62% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2024-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| FAT BRANDS INC | 15 | Q2 2024 | 0.6% |
| XTANT MED HLDGS INC | 13 | Q2 2024 | 6.2% |
| SURROZEN INC | 12 | Q2 2024 | 0.0% |
| ADMA BIOLOGICS INC | 11 | Q2 2024 | 6.9% |
| CHINOOK THERAPEUTICS INC | 11 | Q2 2023 | 8.9% |
| INSMED INC | 11 | Q2 2024 | 5.2% |
| NEXGEL INC | 11 | Q2 2024 | 0.1% |
| NOCTURNE ACQUISITION CORP | 11 | Q1 2024 | 0.1% |
| CINGULATE INC | 11 | Q2 2024 | 0.1% |
| NLS PHARMACEUTICS LTD | 11 | Q2 2024 | 0.0% |
View Altium Capital Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| CEMTREX INC | May 08, 2024 | 36,984 | 10.0% |
| Sunshine Biopharma, Inc | February 21, 2024 | 3,727,984 | 10.0% |
| Evoke Pharma Inc | February 20, 2024 | 822,986 | 9.7% |
| ALIMERA SCIENCES INC | February 13, 2024 | 2,660,000 | 5.0% |
| Cyclacel Pharmaceuticals, Inc. | February 13, 2024 | 37,982 | 5.0% |
| GRI BIO, Inc. | February 13, 2024 | 1,269,210 | 5.0% |
| Marpai, Inc.Sold out | February 13, 2024 | 0 | 0.0% |
| NovaBay Pharmaceuticals, Inc. | February 13, 2024 | 67,457 | 5.0% |
| Volcon, Inc. | February 13, 2024 | 1,666,665 | 9.9% |
| Xtant Medical Holdings, Inc. | February 13, 2024 | 8,027,593 | 6.2% |
View Altium Capital Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| N-PX | 2024-08-26 |
| SC 13G | 2024-08-16 |
| 13F-HR | 2024-08-15 |
| SC 13G | 2024-08-09 |
| SC 13G | 2024-08-09 |
| 13F-HR | 2024-05-15 |
| SC 13G | 2024-05-08 |
| SC 13G | 2024-02-21 |
| SC 13G | 2024-02-20 |
| 13F-HR | 2024-02-14 |
View Altium Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.